Sign Up to like & get
recommendations!
1
Published in 2021 at "Nutrients"
DOI: 10.3390/nu13030840
Abstract: Background: Glucose transporter type 1 deficiency syndrome (GLUT1DS) is caused by mutations in the SLC2A1 gene and produces seizures, neurodevelopmental impairment, and movement disorders. Ketogenic dietary therapies (KDT) are the gold standard treatment. Similar symptoms…
read more here.
Keywords:
positive negative;
negative patients;
slc2a1 positive;
deficiency syndrome ... See more keywords